Novo Nordisk’s global growth cools to 6.4%, but India and APAC defy slump
In a year when global operating profit dipped 0.5% due to restructuring costs, APAC sales rose 19%, or 25% at constant exchange rates, far outpacing the company’s global growth rate
In a year when global operating profit dipped 0.5% due to restructuring costs, APAC sales rose 19%, or 25% at constant exchange rates, far outpacing the company’s global growth rate
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
